Physician

Nicolas Saikali, MD

According to 2025 Medicare claims, Nicolas Saikali, MD (NPI: 1821228511) practices neurology in the Buffalo-Cheektowaga, NY market, with the plurality of this provider's patient population coming from Erie, NY. This provider's primary affiliated billing organization is DENT NEUROLOGIC GROUP LLP (NPI: 1497850911; TIN: 161582336) and primary practice location at 14127-1577.

Saikali's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 126 traditional Medicare patients, billed 21,072 HCPCS/CPT codes, and received $433,666 in Medicare payments. The top billing code was 64615 (Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face). Part D data shows 439 prescription claims across 133 beneficiaries totaling $132,062 in drug costs, led by Nurtec Odt (Rimegepant Sulfate). 2020 DME data shows 21 claims. Open Payments data shows 430 records totaling $216,969. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $780,224 to $433,666. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $1,946 and ending at $1,336.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	528	49,230	$780,224
2016	594	77,580	$1,104,076
2017	528	81,705	$1,042,134
2018	353	48,288	$586,244
2019	213	21,422	$247,223
2020	177	22,280	$235,628
2021	209	22,784	$279,470
2022	178	20,360	$269,688
2023	154	26,475	$563,808
2024	126	21,072	$433,666

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	232	1,460	$134,361
2016	274	1,590	$214,007
2017	296	1,821	$223,275
2018	285	2,022	$252,439
2019	287	1,833	$260,688
2020	259	1,559	$344,381
2021	188	689	$276,921
2022	192	669	$303,382
2023	188	693	$273,898
2024	133	439	$132,062

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	12	$327
2018	N/R	N/R	N/R
2019	N/R	15	$362
2020	N/R	21	$619
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
64615	Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face	16	42	$108
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	40	40	$105
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	17	18	$77
J0585	Injection, onabotulinumtoxina, 1 unit	16	8,355	$5
J7050	Infusion, normal saline solution, 250 cc	19	35	$1

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Nurtec Odt	Rimegepant Sulfate	29	788	$29,351
Ubrelvy	Ubrogepant	25	646	$27,968
Emgality Pen	Galcanezumab-Gnlm	23	810	$19,943
Sumatriptan Succinate	Sumatriptan Succinate	42	1,252	$1,229
Pregabalin	Pregabalin	15	450	$1,053

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	421	$192,491	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	9	$24,478	ABBVIE INC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Nicolas Saikali, MD?

Tedicare shows public-source Medicare data for Nicolas Saikali, MD (NPI 1821228511), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nicolas Saikali, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Nicolas Saikali, MD?

Nicolas Saikali, MD is linked to DENT NEUROLOGIC GROUP LLP (billing NPI 1497850911) in the available physician profile data.

Does Nicolas Saikali, MD have Open Payments data?

Nicolas Saikali, MD has 430 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.